Rocket Doctor AI Deepens Google Ties to Shape Future of Healthcare

VANCOUVER, BC – November 26, 2025 – In an era where artificial intelligence is rapidly reshaping industries, the healthcare sector stands on the precipice of its most significant transformation. At the center of this shift is Rocket Doctor AI, a digital health company that is moving beyond simply using AI tools to actively co-developing the future of medical technology, underscored by a deepening collaboration with Google.

Dr. Bill Cherniak, CEO of Rocket Doctor Inc., a wholly-owned subsidiary of Rocket Doctor AI, recently took the stage at the prestigious Google Accelerator Alumni Summit in Mexico City. In front of an audience of global founders, he was not just another participant but a featured panelist—representing the only healthcare company selected to speak. His presence signaled a pivotal moment, highlighting the company's unique position in deploying responsible and accessible AI in one of the world's most critical and complex fields.

Forging a Strategic Alliance with Silicon Valley

The invitation from Google was more than ceremonial. It provided Rocket Doctor AI with direct access to the minds shaping the next generation of artificial intelligence, including senior leaders from Google DeepMind and its core engineering teams. These closed-door sessions focused on product planning and future roadmap development, giving the digital health firm a rare opportunity to influence the tools it will one day use.

This strategic alignment is built on a solid technical foundation. The company’s entire digital health platform, including its proprietary Global Library of Medicine (GLM), is built on Google Cloud. Its flagship “AI Nurse” platform, a conversational AI designed to support patients and clinicians, currently leverages Google Gemini. Now, with the recent launch of Gemini 3.0, Rocket Doctor AI is exploring how this more powerful and capable model can unlock new efficiencies and create more intuitive, clinically aligned tools.

“It is an incredible honor to be a part of the Google Accelerator ecosystem,” said Dr. Bill Cherniak, CEO of Rocket Doctor Inc. “Being at the event also gave us direct access to some of the senior leadership and engineering teams at Google, which will be invaluable to our growth and success.”

This collaboration is crucial. While many tech companies are retrofitting AI into existing workflows, Rocket Doctor AI’s approach involves embedding it from the ground up, with direct input from the architects of the technology. As Dr. Essam Hamza, CEO of the parent company Rocket Doctor AI, noted, the new capabilities unlocked by Gemini 3.0 allow the company to “move faster and build smarter,” accelerating its mission to deliver high-quality care.

From Accelerator to Market Expansion

Rocket Doctor AI’s strategy is not confined to high-level tech collaborations. Just as the Google summit concluded, Dr. Cherniak presented virtually at the Heal.LA Accelerator Demo Day. This marked the graduation from a nine-month program run by the Larta Institute, a respected organization that fosters technology commercialization. His presentation to over 100 healthcare stakeholders from across Southern California—including health plans, hospitals, and government bodies—demonstrates a clear strategy for on-the-ground implementation.

Participation in accelerators like Heal.LA is a key part of the company's blueprint for scaling. These programs provide vital mentorship, regulatory guidance, and, most importantly, access to regional healthcare networks. This is particularly relevant as the company expands its footprint in the United States. Recently, Rocket Doctor AI secured a virtual care partnership with the Central California Alliance for Health, a Medi-Cal plan serving approximately 450,000 members, and became an in-network provider for New York's 6.9 million Medicaid beneficiaries. This demonstrates a tangible commitment to serving public health populations, a core part of its mission.

Financially, the company is showing signs of maturation. After its acquisition of Rocket Doctor Inc. in April 2025, the publicly traded firm (CSE: AIDR) reported its first-ever revenues of C$0.5 million in the second quarter with a strong gross margin of 89%. While still operating at a net loss—a common trait for a rapidly scaling growth-stage company—these figures signal the beginning of commercial traction and a viable business model.

The Technology Bridging Healthcare Gaps

At the heart of Rocket Doctor AI's value proposition is its physician-built technology designed to tackle systemic healthcare challenges. The company's platform functions as a “Shopify for physicians,” an AI-powered marketplace that empowers doctors to launch and manage their own virtual or hybrid practices. By reducing administrative burdens, this model restores physician autonomy and creates more time for meaningful patient interactions. To date, the platform has empowered over 300 physicians and facilitated more than 700,000 patient visits.

The clinical intelligence behind its tools comes from the Global Library of Medicine (GLM), a decision support system developed over a decade with input from hundreds of physicians worldwide. The company emphasizes that this physician-curated AI system does not “hallucinate”—a critical distinction in a field where accuracy is paramount. This claim is bolstered by significant federal validation, including a $2 million Phase 2 grant from the U.S. National Institutes of Health (NIH) to further develop the GLM.

This technology is being deployed to address profound disparities in healthcare access. The company’s mission is explicitly focused on reaching underserved, rural, and remote communities in Canada and the U.S. where access to primary care is often limited. By enabling virtual care that is both efficient for doctors and accessible for patients, the platform has the potential to become a critical piece of infrastructure for achieving health equity.

Navigating a Complex and Competitive Landscape

Rocket Doctor AI is not operating in a vacuum. The AI digital health market is a crowded and fiercely competitive space, with companies vying to offer solutions for everything from automated clinical documentation to AI-powered diagnostics and virtual nursing. Furthermore, the regulatory environment is complex and constantly evolving. Health authorities like the FDA in the U.S. and Health Canada are establishing rigorous frameworks for Software as a Medical Device (SaMD), demanding transparency, bias mitigation, and robust validation to ensure patient safety.

In this context, Rocket Doctor AI's physician-led approach and its clinically validated GLM serve as key differentiators. By focusing on building a trustworthy, non-hallucinating AI engine and empowering physicians directly, the company aims to build confidence among both clinicians and patients. Its deep partnership with Google provides a technological edge, while its focus on navigating regional healthcare systems through programs like Heal.LA demonstrates a pragmatic understanding of the market.

Looking ahead to 2026, the company is poised to leverage these strategic advantages. By combining advanced foundational models like Gemini 3.0 with a physician-centric platform and a clear mission to expand access, Rocket Doctor AI is not just participating in the digital health revolution; it is actively working to ensure that the future of healthcare is more scalable, equitable, and patient-centered for all.